Publication Listing for the MeSH term pancreaticoduodenectomy. Found 11 abstracts
Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SR, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, Shead DA. Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2012 Jun;10(6):703-13. PMCID: not NIH funded |
Gumbs AA, Rodriguez-Rivera AM, Hoffman JP. Minimally invasive pancreatic surgery of the entire gland: initial experience. Minerva Chirurgica. 2011 Aug;66(4):269-80. |
Regine WF, Winter KA, Abrams R, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Rich TA, Willett CG. Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the US Intergroup/RTOG 9704 Phase III Trial. Annals of Surgical Oncology. 2011 May;18(5):1319-26. PMCID: NIHMS323431 [approved 10-18-12] |
Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG. THE INFLUENCE OF TOTAL NODES EXAMINED, NUMBER OF POSITIVE NODES, AND LYMPH NODE RATIO ON SURVIVAL AFTER SURGICAL RESECTION AND ADJUVANT CHEMORADIATION FOR PANCREATIC CANCER: A SECONDARY ANALYSIS OF RTOG 9704. International Journal of Radiation Oncology Biology Physics. 2011 Dec;81(5):1328-35. PMCID: PMC3038247 |
Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, Haluszka O, Tokar JL, Hall MJ, Denlinger CS, Astsaturov I, Hoffman JP. Defining Venous Involvement in Borderline Resectable Pancreatic Cancer. Annals of Surgical Oncology. 2010 Nov;17(11):2832-8. PMCID: no NIH funding |
Hoffman JP, Lipsitz S, Pisansky T, Weese JL, Solin L, Benson AB. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An eastern cooperative oncology group study. Journal of Clinical Oncology. 1998 Jan;16(1):317-23. |
Hoffman JP, Pendurthi TK, Ross E, Yeung RS. Preoperative radiation therapy and chemotherapy for adenocarcinoma of the pancreas. Hepato-Gastroenterology. 1998 May;45(21):634-7. |
Montgomery RC, Hoffman JP, Riley LB, Rogatko A, Ridge JA, Eisenberg BL. Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas. Annals of Surgical Oncology. 1997 Oct;4(7):551-6. |
Hoffman JP, Odwyer P, Agarwal P, Salazar H, Ahmad N. Preoperative chemoradiotherapy for localized pancreatic carcinoma - A perspective. Cancer. 1996 Aug;78(3):592-7. |
Ballard RB, Hoffman JP, Guttman MC, Barber L, Litwin S. How Accurate Is Size Measurement of Pancreas Cancer Masses by Computed Axial-Tomography (Ct) Scanning. American Surgeon. 1995 Aug;61(8):686-91. |
Coia L, Hoffman J, Scher R, Weese J, Solin L, Weiner L, Eisenberg B, Paul A, Hanks G. Preoperative Chemoradiation for Adenocarcinoma of the Pancreas and Duodenum. International Journal of Radiation Oncology Biology Physics. 1994 Aug 30;30(1):161-7. |
MeSH cloud from publications including the MeSH term pancreaticoduodenectomy
pancreaticoduodenectomy
carcinoma
cancer
chemoradiation
adenocarcinoma
radiation
experience
head
chemotherapy
resection
survival
curative resection
computed-tomography
therapy
chemoradiotherapy
ductal adenocarcinoma
margin status
2nd-line therapy
preoperative irradiation
randomized controlled-trial
index
irradiation
laparoscopic
ca-19-9
staplers
adjuvant chemotherapy
antineoplastic
Nodal ratio
institution
long-term survival
complications
pancreatectomy
phase-ii
Lymph node
combination
Radiation therapy
pancreatic cancer
beam irradiation
expert consensus statement
prognosis
tumor-marker
recurrence
helical ct
prognostic-factors
esophageal cancer
outcomes
radiation effects
vascular resection
Pancreatic cancer
462 distal pancreatectomies
radiotherapy
pancreas
pancreatic neoplasms
diagnosis
extended lymphadenectomy
5-fluorouracil
ampulla
Pancreatoduodenectomy
fluorouracil
invasive
CA 19-9
duodenal cancer
1993 o ml-international journal of radiation oncology biology physics-v26-p483
adjuvant
Pancreaticoduodenectomy
clinical-trials
Laparoscopy
5-
cancer statistics
decrease fistula rates
agents
radiation-therapy
antigen
minimally Surgical procedures
duration
trial
Pancreatic neoplasms
standard
utility